Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Veracyte (VCYT) EPS (Basic) (2016 - 2025)

Historic EPS (Basic) for Veracyte (VCYT) over the last 14 years, with Q3 2025 value amounting to $0.24.

  • Veracyte's EPS (Basic) rose 2000.0% to $0.24 in Q3 2025 from the same period last year, while for Sep 2025 it was $0.39, marking a year-over-year increase of 40000.0%. This contributed to the annual value of $0.32 for FY2024, which is 13094.03% up from last year.
  • Latest data reveals that Veracyte reported EPS (Basic) of $0.24 as of Q3 2025, which was up 2000.0% from -$0.01 recorded in Q2 2025.
  • In the past 5 years, Veracyte's EPS (Basic) ranged from a high of $0.24 in Q3 2025 and a low of -$0.66 during Q1 2021
  • Moreover, its 5-year median value for EPS (Basic) was -$0.12 (2022), whereas its average is -$0.11.
  • Per our database at Business Quant, Veracyte's EPS (Basic) tumbled by 66000.0% in 2023 and then skyrocketed by 55000.0% in 2025.
  • Quarter analysis of 5 years shows Veracyte's EPS (Basic) stood at -$0.14 in 2021, then skyrocketed by 64.29% to -$0.05 in 2022, then plummeted by 660.0% to -$0.38 in 2023, then surged by 117.67% to $0.07 in 2024, then surged by 257.34% to $0.24 in 2025.
  • Its EPS (Basic) was $0.24 in Q3 2025, compared to -$0.01 in Q2 2025 and $0.09 in Q1 2025.